(Natural News) A study by British researchers found that patients may still have some form of immunity to COVID-19 long after the antibodies specific to the Wuhan coronavirus (SARS-CoV-2) have fallen below detectable levels. Researchers from Public Health England (PHE) and the U.K. Coronavirus Immunology Consortium (UK-CIC), a public research initiative established to stem the COVID-19 pandemic, found that the T […]

(Natural News) The Food and Drug Administration (FDA) gave Eli Lilly’s antibody drug emergency-use authorization on Monday, Nov. 9. Early data has strongly suggested that the pharmaceutical company’s antibody drug is effective at keeping people with mild to moderate cases of the Wuhan coronavirus (COVID-19) from needing to get admitted to a hospital. The FDA extended the emergency approval […]

(Natural News) A U.K. study raises fresh concerns that immunity to the Wuhan coronavirus (COVID-19) is short-lived and that people may be reinfected after recovering the first time. Researchers from the University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) found that the number of antibodies specific to SARS-CoV-2, the coronavirus responsible for COVID-19, drop by half less […]

(Natural News) The third such study in recent days to make this suggestion, a new paper published by researchers from Guy’s and St. Thomas’ National Health Service Foundation Trust in London has determined that the antibodies developed after infection with the Wuhan coronavirus (COVID-19) only last a very short time, meaning any future vaccine for […]

(Natural News) American pharmaceutical firm Eli Lilly has agreed to supply the U.S. government with its experimental COVID-19 antibody medication. The company announced Oct. 28 that it will provide an initial 300,000 vials of the bamlanivimab antibody-drug amounting to $375 million, contingent on emergency use authorization (EUA) from the Food and Drug Administration (FDA). Eli […]

(Natural News) Mainstream science has determined that Wuhan coronavirus (COVID-19) antibodies are “seasonal,” meaning people who get vaccinated will have to get jabbed again and again in order to maintain lasting “immunity.” Since COVID-19 antibodies are said to “degrade” every 4-6 months, the apparent expectation is that members of the public will agree to get […]

(Natural News) White House physician Dr. Sean Conley released a memorandum Oct. 7, saying that President Donald Trump has developed antibodies against the coronavirus. Addressed to White House Press Secretary Kayleigh McEnany, the memo also said that Trump has been “fever-free for more than four days” and has not experienced any COVID-19 symptoms for over 24 […]

(Natural News) Less than 10 percent of American adults had evidence of seroconversion — the development of virus-specific antibodies — in July, despite the United States replacing China as the country with the highest number of confirmed coronavirus cases as early as March. Researchers at Stanford University reported this finding in an article published in The Lancet last week, […]

(Natural News) People infected by the coronavirus develop long-term immunity to COVID-19. A new study published August 14 in the journal Cell presented evidence that the immune system is capable of preventing the recurrence of the disease, thanks to specialized immune cells that commit the virus into memory. Memory T cells are a type of white blood cell […]

(Natural News) There’s been a lot of talk in recent months about how the coronavirus pandemic will end. Some are putting their hopes on a vaccine, while others believe it would be enough to find an effective treatment for those who are hit with the more severe form of the disease. However, some experts are […]